11,250€
1,08%
Echtzeit-Aktienkurs Astellas Pharma Inc.
Bid:
Ask:
Echtzeit-Chart der Astellas Pharma Inc. Aktie
Börsenkurse Astellas Pharma Inc.
| Börse Stuttgart | - | - | - | - | 11,250€ | 1,08% |
| Tradegate | - | - | - | - | 11,048€ | -0,38% |
| Lang & Schwarz | - | - | - | - | 11,030€ | -2,00% |
| Echtzeit Euro | - | - | - | - | 11,045€ | -0,94% |
| Börse Frankfurt | - | - | - | - | 10,970€ | 1,86% |
| gettex | - | - | - | - | 11,055€ | -1,32% |
Profil der Astellas Pharma Inc. Aktie
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.